leisure time -WSS

leisure time

author：leisure time 2025-10-01 02:12:27 - browse：69544

PORTRAIT of Michelle Monje smiling with trees in the background. -- health coverage from STAT. — New research led by Stanford neuro-oncologist Michelle Monje shines light on the electrochemical signaling pathway between neurons and cancer cells. Courtesy MacArthur Foundation

The idea that cancer can hijack brain plasticity — subverting supple connections in the healthy brain that ordinarily lead to learning and memory formation — is gaining traction.

First reported in Cell in 2015, research led by Stanford neuro-oncologist Michelle Monje showed that active nerve cells could promote the growth of high-grade gliomas, a form of brain cancer with a poor prognosis. Four years later, her lab revealed in a Nature paper that synapses between these neurons and gliomas spurred tumor growth, and last year, the team demonstrated how these same synapses revved up glioblastoma’s spread.

There are still many questions about precisely how this process unfolds, and it’s too soon to say how solutions might be reached. But in a new paper published in Nature on Wednesday, Monje’s team solves another part of the puzzle, shining light on the electrochemical signaling pathway between neurons and cancer cells.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： WHO may add ‘noma' to its list of neglected tropical diseases

leisure time

WSS

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Global childhood vaccinations edge closer to pre

Can CDC director Mandy Cohen drive consensus in Washington?

Celiac disease study examines precisely how gluten triggers injury

Congress likely to miss an opportunity to fix drug shortages issue

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

explore

leisure time

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Maker of FluMist seeks to allow at

Psychedelics group wrestles with new pharma identity

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Supreme Court strikes down use of affirmative action

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

State Dept. review finds Biden bears some blame for Afghanistan failures

Care demand spikes challenge UnitedHealth’s provider arm

ChatGPT in medicine: STAT answers readers' burning questions

Eli Lilly to pay $200M for Beam’s stake in gene

knowledge

Why Sanofi got shellacked over its spinoff

Involuntary treatment for addiction doesn't work

Physician subsidies by hospitals soar in wake of No Surprises Act

Involuntary treatment for addiction doesn't work

Europe sees delivery challenges ahead on Alzheimer's therapies

Federal judge rules Oregon’s tough new gun law is constitutional

hotspot

leisure time

leisure time

focus